Colorectal cancer screening of the general population in East Asia

Digestive Endoscopy

Volumn 28, Issue 3, 2016, Pages 243-249

  Sano, Yasushi ^a   Byeon, Jeong Sik ^b   Li, Xiao Bo ^c   Wong, Martin C S ^d   Chiu, Han Mo ^f   Rerknimitr, Rungsun ^g   Utsumi, Takahiro ^a   Hattori, Santa ^a   Sano, Wataru ^a   Iwatate, Mineo ^a   Chiu, Philip ^e   Sung, Joseph ^e  

^a National Hospital Organization   (Japan)

^b University of Ulsan College of Medicine   (South Korea)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Prince of Wales Hospital   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Asia; colonoscopy; colorectal cancer; fecal occult blood test; screening

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; CHINA; COLONOSCOPY; COLORECTAL CANCER; COST BENEFIT ANALYSIS; EAST ASIAN; HONG KONG; HUMAN; JAPAN; KOREA; POPULATION RESEARCH; POPULATION SIZE; REVIEW; TAIWAN; THAILAND; ADULT; AGED; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FAR EAST; FEMALE; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED;

ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FAR EAST; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED;

EID: 84961742850     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12579     Document Type: Review

References (36)

1. Hirabayashi Y, Tanaka S,. Comparison of time trends in colorectal cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol IV-VIII. Jpn. J. Clin. Oncol. 2007; 37: 325-7.
2. Winawer SJ, Zauber AG, Ho MN, et al., Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993; 329: 1977-81.
3. Winawer SJ, Zauber AG, O'Brien MJ, et al., Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N. Engl. J. Med. 1993; 328: 901-6.
4. Saito H, Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J. Med. Screen. 2006; 13 (Suppl 1): S6-7.
5. Hardcastle JD, Chamberlain JO, Robinson MHE, et al., Randomized controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
6. Nakajima M, Saito H, Soma Y, et al., Prevention of advanced colorectal cancer by screening using the immunochemical fecal occult blood test: a case-control study. Br. J. Cancer 2003; 89: 23-8.
7. Sano Y, Fujii T, Matsuda T, et al., Study design and patient recruitment for the Japan Polyp Study. Open Access J. Clin. Trials 2014; 6: 37-44.
8. Hisamichi S, Fukao A, Fujii Y, et al., Mass screening for colorectal cancer in Japan. Cancer Detect. Prev. 1991; 15: 351-6.
9. Lee KJ, Inoue M, Otani T, et al., Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect. Prev. 2007; 31: 3-11.
10. Shin A, Kim K-Z, Jung K-W, et al., Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res. Treat. 2012; 44: 219-26.
11. Lee W-C, Breast, stomach and colorectal cancer screening in Korea. J. Med. Screen. 2006; 13: S20-2.
12. Shin A, Choi KS, Jun JK, et al., Validity of fecal occult blood test in the National Cancer Screening Program, Korea. PLoS One 8: e79292.
13. Lee B-I, Hong SP, Kim S-E, et al., Korean guidelines for colorectal cancer screening and polyp detection. Clin. Endosc. 2012; 45: 25-43.
14. Yang D-H, Hong SN, Kim Y-H, et al., Korean guidelines for postpolypectomy colonoscopy surveillance. Clin. Endosc. 2012; 45: 44-61.
15. Zheng S, Chen K, Liu X, et al., Cluster randomization trial of sequence mass screening for colorectal cancer. Dis. Colon Rectum 2003; 46: 51-8.
16. Meng W, Cai S-R, Zhou L, et al., Performance value of high-risk factors in colorectal cancer screening in China. World J. Gastroenterol. 2009; 15: 6111-6.
17. Li S, Wang H, Hu J, et al., New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: Results of a prospective multicenter study in Chinese patients. Int. J. Cancer 2006; 118: 3078-83.
18. Wong MC, Lam TY, Tsoi KK, et al., A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut 2014; 63: 1130-6.
19. Cai SR, Zhang SZ, Zhu HH, et al., Barriers to colorectal cancer screening: A case-control study. World J. Gastroenterol. 2009; 15: 2531-6.
20. Sung JJY, Lau JYW, Goh KL, Leung WK, for the Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6: 871-6.
21. Hospital Authority. Hong Kong Cancer Registry. [Cited 5 August 2015.] Available from URL: http://www.ha.org.hk/cancereg
22. Cancer Expert Working Group (CEWG) on Cancer Prevention and Screening. Prevention and Screening for Colorectal Cancer. [Cited 5 August 2015.] Available from URL: http://www.chp.gov.hk/files/pdf/colorectal-ca-en.pdf.
23. Sung JJ, Chan FK, Chiu HM, et al., The Asia-Pacific Working Group on Colorectal Cancer Screening. An Updated Asia-Pacific Consensus Recommendation on Colorectal Cancer Screening. Gut 2015; 64: 121-32.
24. Yeoh KG, Ho KY, Chiu HM, et al., The Asia-Pacific Working Group on Colorectal Cancer. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011; 60: 1236-41.
25. Taiwan Cancer Registry. Cancer Statistics: Cancer Incidence and Mortality Rates in Taiwan. [Cited 5 August 2015.] Available from URL: http://tcr.cph.ntu.edu.tw/main.php?Page=N2.
26. Mandel JS, Bond JH, Church TR, et al., Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993; 328: 1365-71.
27. Mandel JS, Church TR, Bond JH, et al., The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 2000; 343: 1603-7.
28. Chiu HM, Chen SL, Yen AM, et al,. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 2015; 121: 3221-9.
29. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L,. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 2009; 150: 1-8.
30. Doubeni CA, Weinmann S, Adams K, et al., Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann. Intern. Med. 2013; 158: 312-20.
31. Nishihara R, Wu K, Lochhead P, et al., Long-term colorectal cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 2013; 369: 1095-105.
32. Hospital-Based Cancer Registry Annual Report 2012. [Cited 11 August 2015.] Available from URL: http://www.nci.go.th/th/File-download/Nci%20Cancer%20Registry/Hospital-Based%20NCI%202012%20Total.pdf.
33. Byeon JS, Yang SK, Kim TI, et al., Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest. Endosc. 2007; 65: b1015-22.
34. Institute of Population and Social Research Mahidol University. Population of Thailand BE 2557. [Cited 12 August 2015.] Available from URL: http://www.ipsr.mahidol.ac.th/ipsr-th/index.aspx
35. Yeoh KG, Ho KY, Chiu HM, et al., The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011; 60: 1236-41.
36. Aniwan S, Rerknimitr R, Kongkam P, et al., A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants. Gastrointest. Endosc. 2015; 81: 719-27.